U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. The Food and Drug Administration on Friday OK'd naloxone spray from Israel's Teva ...

Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...

The US Food and Drug Administration (FDA) has granted final approval for the first generic naloxone hydrochloride nasal spray (Narcan, Teva Pharmaceuticals) that can stop or reverse the effects of an ...

With high-profile inhalable drugs coming off patent, the prospects for the generic sector should be good – but only if companies can overcome production, regulatory and litigation hurdles. The ...

The Food and Drug Administration has approved the first generic nasal spray to reverse opioid overdoses. Generic naloxone has been available for years in an injectable form in a health care setting, ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved the first generic nasal spray of the opioid overdose antidote Narcan for use in a ...

(AP) — The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or ...

ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the United States Food and Drug Administration an Abbreviated New Drug Application for azelastine hydrochloride nasal spray (0.15 ...

The FDA has approved an abbreviated new drug application for naloxone hydrochloride nasal spray, paving the way for the opioid overdose treatment to be available without a prescription. According to a ...

(Washington-AP) February 22, 2006 - Some people with seasonal and chronic allergies could now have a cheaper alternative to treat their symptoms. Regulators have approved the first generic version of ...

Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health ...